Page last updated: 2024-09-04

2-iodolysergic acid diethylamide and Neuroblastoma

2-iodolysergic acid diethylamide has been researched along with Neuroblastoma in 1 studies

*Neuroblastoma: A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51) [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Molinoff, PB; Unsworth, CD1

Other Studies

1 other study(ies) available for 2-iodolysergic acid diethylamide and Neuroblastoma

ArticleYear
Characterization of a 5-hydroxytryptamine receptor in mouse neuroblastoma N18TG2 cells.
    The Journal of pharmacology and experimental therapeutics, 1994, Volume: 269, Issue:1

    Topics: Adenylyl Cyclases; Animals; Binding Sites; Cyclic AMP; Iodine Radioisotopes; Lysergic Acid Diethylamide; Mice; Neuroblastoma; Radioligand Assay; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Stimulation, Chemical; Tumor Cells, Cultured

1994